Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $24.4400 (1.83%) ($23.5600 - $24.6800) on Thu. May. 21, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.28% (three month average) | RSI | 60 | Latest Price | $24.4400(1.83%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO advances 0.6% a day on average for past five trading days. | Weekly Trend | HALO advances 0.9% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IBB(50%) IWO(50%) IWM(46%) IWC(44%) ARKG(43%) | Factors Impacting HALO price | HALO will decline at least -2.14% in a week (0% probabilities). VIXM(-31%) UUP(-15%) VXX(-14%) TLT(-2%) IGOV(-1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.14% (StdDev 4.28%) | Hourly BBV | 0 () | Intraday Trend | 1.5% | | | |
|
5 Day Moving Average | $24.05(1.62%) | 10 Day Moving Average | $24.02(1.75%) | 20 Day Moving Average | $23.72(3.04%) | To recent high | -1.5% | To recent low | 75.8% | Market Cap | $3.34b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |